These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2897910

  • 61. Drugs: not the only treatment.
    Keith SJ.
    Hosp Community Psychiatry; 1982 Oct; 33(10):793. PubMed ID: 6127306
    [No Abstract] [Full Text] [Related]

  • 62. Cresting.
    Fox V.
    Psychiatr Serv; 2004 Jun; 55(6):641-2. PubMed ID: 15175459
    [No Abstract] [Full Text] [Related]

  • 63. A critical assessment of antipsychotic drug monitoring.
    Waraska J, Nagle JD.
    Clin Lab Med; 1987 Jun; 7(2):435-52. PubMed ID: 2886247
    [Abstract] [Full Text] [Related]

  • 64. The ageing brain, neuroleptic drugs and the enigma of schizophrenia.
    Waddington JL.
    Ir J Med Sci; 1988 May; 157(5):135-41. PubMed ID: 2906348
    [No Abstract] [Full Text] [Related]

  • 65. The administration of neuroleptic drugs decreased the arousal level, as reflected in a reduction of early CNV amplitude.
    Sato Y, Yabe H, Hiruma T, Sutoh T, Shinozaki N, Nashida T, Kaneko S, Saito F, Fukushima Y.
    Schizophr Res; 1999 Nov 09; 40(1):84-6. PubMed ID: 10541012
    [No Abstract] [Full Text] [Related]

  • 66. Tea drinking and neuroleptic dosage.
    Cheung HK.
    Am J Psychiatry; 1981 Nov 09; 138(11):1517. PubMed ID: 6117206
    [No Abstract] [Full Text] [Related]

  • 67. Negative symptoms and neuroleptic response.
    Chaturvedi SK.
    Can J Psychiatry; 1986 Aug 09; 31(6):599-600. PubMed ID: 2875782
    [No Abstract] [Full Text] [Related]

  • 68. Validity and clinical utility of neuroleptic-facilitated electroencephalography in psychotic patients.
    Neil JF, Merikangas JR, Davies RK, Himmelhoch JM.
    Clin Electroencephalogr; 1978 Jan 09; 9(1):38-48. PubMed ID: 31995
    [No Abstract] [Full Text] [Related]

  • 69. Small animal model for evaluating neuroleptic potency.
    Rosenberg JM, Lau-Cam CA.
    J Pharm Sci; 1980 Jan 09; 69(1):74-7. PubMed ID: 6101619
    [No Abstract] [Full Text] [Related]

  • 70. [Clinical findings on the pharmacokinetics and pharmacodynamics of a new Czechoslovak-manufactured neuroleptic, isofloxythepin].
    Kazdová E, Lapka R, Rejholec V.
    Cesk Psychiatr; 1986 Apr 09; 82(2):97-100. PubMed ID: 2873898
    [No Abstract] [Full Text] [Related]

  • 71. Prolactin secretion is not a core dimension of "atypicality".
    Gründer G, Benkert O.
    Psychopharmacology (Berl); 2002 Jun 09; 162(1):93. PubMed ID: 12141276
    [No Abstract] [Full Text] [Related]

  • 72. "Antipsychotic" or "neuroleptic".
    Burton HB.
    J Clin Psychiatry; 1986 Jul 09; 47(7):392. PubMed ID: 2873134
    [No Abstract] [Full Text] [Related]

  • 73. Antipsychotic or neuroleptic?
    Dove MJ.
    J Clin Psychiatry; 1985 Oct 09; 46(10):454-5. PubMed ID: 2864334
    [No Abstract] [Full Text] [Related]

  • 74. Review: most antipsychotic drugs more than double the prolactin levels in children and adolescents.
    Correll C, Kishimoto T, Carlson H.
    Evid Based Ment Health; 2010 May 09; 13(2):54. PubMed ID: 21856617
    [No Abstract] [Full Text] [Related]

  • 75. Serum prolactin levels in schizophrenia: effects of neuroleptic medication - a preliminary study.
    Kuruvilla K, Kuruvilla A, Kanagasabapathy AS.
    Indian J Psychiatry; 1986 Jul 09; 28(3):237-41. PubMed ID: 21927182
    [No Abstract] [Full Text] [Related]

  • 76. Preliminary observations on prolactin activity in human blood.
    SIMKIN B, GOODART D.
    J Clin Endocrinol Metab; 1960 Aug 09; 20():1095-106. PubMed ID: 14446849
    [No Abstract] [Full Text] [Related]

  • 77. The Effects of Prolactin-Raising and Prolactin-Sparing Antipsychotics on Prolactin Levels and Bone Mineral Density in Schizophrenic Patients.
    Doğan Bulut S, Bulut S, Tüzer V, Ak M, Ak E, Kisa C, Aydemir Ç, Göka E.
    Noro Psikiyatr Ars; 2014 Sep 09; 51(3):205-210. PubMed ID: 28360627
    [Abstract] [Full Text] [Related]

  • 78. Unusually high prolactin level for medication-induced hyperprolactinemia: a case report.
    Akbas EM, Gungor A, Ozdemir C, Bilen H.
    Eurasian J Med; 2013 Jun 09; 45(2):138-40. PubMed ID: 25610268
    [Abstract] [Full Text] [Related]

  • 79. Pharmacological causes of hyperprolactinemia.
    Torre DL, Falorni A.
    Ther Clin Risk Manag; 2007 Oct 09; 3(5):929-51. PubMed ID: 18473017
    [Abstract] [Full Text] [Related]

  • 80. Drugs and prolactin.
    Molitch ME.
    Pituitary; 2008 Oct 09; 11(2):209-18. PubMed ID: 18404390
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.